Log In
Print
BCIQ
Print
Print this Print this
 

GSK961081 (961081) (formerly TD-5959)

  Manage Alerts
Collapse Summary General Information
Company Theravance Inc.
DescriptionBifunctional muscarinic receptor antagonist and beta 2 agonist (MABA)
Molecular Target Muscarinic receptor ; Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner

GlaxoSmithKline plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today